Forty-year-old Arturo Nieves works as production director of the shrimp farming company Aquacultores del Mar Azul, located in the state of Sinaloa, Mexico.
As land-based and RAS facilities proliferate, they need a way to address their waste footprint. “Circular aquaculture” could be the way forward – but should producers rely on bacteria, algae or biogas to achieve circularity?
Leading vannamei shrimp producers from Guatemala, Venezuela and Sri Lanka – as well as some of the new generation of RAS and biofloc farmers – are set to discuss their operations at a special session of the Global Shrimp Forum on 8 September.
Portuguese software startup Sensaway* recently landed EEA funding, which could not only help the company develop its software, but also improve the European aquaculture sector – both in Portugal and further afield.
Ramon Perez, co-founder of Alpha Aqua, produces RAS units, with a twist – focusing mainly on designing modular systems for both cold and warmwater species.
Yit Tung – who farms mud crabs, shrimp and tilapia in Malaysia – has no regrets about swapping a steady job as an engineer in the oil and gas sector for starting up his own aquaculture venture, RAS Aquaculture.
Dagón – Israel’s pioneering hatchery and leading fish farmer – offers a tantalising glimpse of how aquaculture in the MENA region is evolving and of the emerging species that have the greatest commercial potential.
The head of a Ukrainian company that specialises in the design and implementation of RAS facilities is determined to bring his team out of Russia to find work in Europe.
The Blue Impact Fund aims to raise up to £75 million to catalyse the growth of truly sustainable aquaculture in the UK – with a focus on projects including the production of seaweed, bivalves and land-based shrimp.
David Dupaul-Chicoine recently established an urban RAS business in Montreal with the capacity to produce up to 30 tonnes of Arctic char a year. Coupled with an innovative and ever-evolving business plan, Opercule is an intriguing addition to North American aq…
Emerging research has shown that nutraceuticals in aquafeed can delay the onset and progress of clinical signs of amoebic gill disease (AGD) in farmed Atlantic salmon.
